/Companies

FIRE1

Dublin, IE · Founded 2014 · 110 employees on LinkedIn · 15 known investors

Find your way into FIRE1

Sign up to see every warm intro you have to FIRE1

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the FIRE1 team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

FIRE1 develops NORM, an implantable sensor placed in the inferior vena cava to directly measure fluid volume in heart failure patients, paired with a self-management platform to help patients engage with their own care. The company runs clinical trials across Europe and the US for people living with heart failure.

Investors · 15

Vensana CapitalreportedMinneapolis

How we know: the VCSheet dataset · Not right? Tell us

Also in the syndicate · 3

Elevage Medical TechnologiesleadMedtronicthe Ireland Strategic Investment Fund

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does FIRE1 do?
FIRE1 develops NORM, an implantable sensor placed in the inferior vena cava to directly measure fluid volume in heart failure patients, paired with a self-management platform to help patients engage with their own care. The company runs clinical trials across Europe and the US for people living with heart failure.
Who are FIRE1's investors?
FIRE1's investors include Andera Partners, Gimv, Ireland Strategic Investment Fund, Lightstone Ventures, Longitude Capital, New Enterprise Associates (NEA), Seventure Partners, Gilde Healthcare and 4 more.
Where is FIRE1 headquartered?
FIRE1 is headquartered in Dublin, IE.